GALECTIN THERAPEUTICS INC (GALT)

US3632252025 - Common Stock

3.45  -0.05 (-1.43%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
38.07M38.35M30.18M23.44M13.44M
Research and Development
32.13M31.74M23.82M17.98M7.47M
Selling, General, and Administrative Expenses
5.94M6.62M6.36M5.47M5.97M
Operating Income
-38.07M-38.35M-30.18M-23.44M-13.44M
Interest Income/Expense
-2.99M-420.00K-350.00K-20.00K140.00K
Income Before Taxes
-41.07M-38.78M-30.53M-23.47M-13.29M
Net Income
-44.80M-38.87M-30.70M-23.60M-20.18M
EBITDA
N/AN/AN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-0.74-0.65-0.52-0.41-0.39
Non GAAP EPS
-0.74-0.65-0.51-0.40-0.43
 
Statistics

All data in USD

Charts